Trials / Completed
CompletedNCT02968368
Study With Oral Ferric Maltol for the Treatment of Iron Deficiency Anemia in Subjects With Chronic Kidney Disease
A Phase 3, Randomized, Placebo Controlled, Prospective, Multicenter Study With Oral Ferric Maltol for the Treatment of Iron Deficiency Anemia in Subjects With Chronic Kidney Disease
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 167 (actual)
- Sponsor
- Shield Therapeutics · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the efficacy of oral ferric maltol compared with placebo in the treatment of IDA in subjects with CKD
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ferric maltol | |
| OTHER | Placebo |
Timeline
- Start date
- 2016-12-01
- Primary completion
- 2018-01-18
- Completion
- 2018-10-10
- First posted
- 2016-11-18
- Last updated
- 2020-11-02
- Results posted
- 2020-05-01
Locations
27 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02968368. Inclusion in this directory is not an endorsement.